We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+17.9%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12.6B
AUM Growth
+$1.99B
Cap. Flow
-$290M
Cap. Flow %
-2.3%
Top 10 Hldgs %
21.14%
Holding
876
New
80
Increased
408
Reduced
263
Closed
68

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$146M
2
CRM icon
Salesforce
CRM
+$65.4M
3
MRK icon
Merck
MRK
+$57.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$50.8M
5
C icon
Citigroup
C
+$46.5M

Sector Composition

Rank Sector Weight
1 Healthcare 34.01%
2 Technology 22.68%
3 Consumer Discretionary 9.38%
4 Financials 7.85%
5 Communication Services 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$434M 3.44%
1,953,583
-82,778
-4% -$17.8M
AAPL icon
2
Apple
AAPL
$4.79T
$426M 3.37%
3,213,416
+1,209,742
+60% +$146M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.17T
$307M 2.43%
3,500,360
+36,460
+1% +$3.07M
AMGN icon
4
Amgen
AMGN
$198B
$304M 2.41%
1,324,190
+61,831
+5% +$14.3M
MRK icon
5
Merck
MRK
$315B
$299M 2.37%
3,832,135
+757,091
+25% +$57.9M
REGN icon
6
Regeneron Pharmaceuticals
REGN
$68.3B
$195M 1.54%
403,637
+80,601
+25% +$43.5M
VRTX icon
7
Vertex Pharmaceuticals
VRTX
$120B
$184M 1.46%
779,539
+221,408
+40% +$50.8M
DHR icon
8
Danaher
DHR
$126B
$177M 1.4%
896,230
+35,631
+4% +$7.14M
AMZN icon
9
Amazon
AMZN
$2.63T
$174M 1.38%
1,071,540
-478,300
-31% -$76.3M
TMO icon
10
Thermo Fisher Scientific
TMO
$196B
$170M 1.35%
365,832
+16,594
+5% +$7.78M
PG icon
11
Procter & Gamble
PG
$347B
$157M 1.24%
1,128,380
+142,454
+14% +$19.9M
GILD icon
12
Gilead Sciences
GILD
$162B
$128M 1.02%
2,204,940
+279,150
+14% +$16.8M
PYPL icon
13
PayPal
PYPL
$49B
$126M 1%
538,736
+4,499
+0.8% +$932K
META icon
14
Meta Platforms (Facebook)
META
$1.59T
$124M 0.98%
455,018
-91,392
-17% -$25.1M
TSM icon
15
TSMC
TSM
$2.18T
$113M 0.9%
1,037,782
+135,961
+15% +$12.9M
BMY icon
16
Bristol-Myers Squibb
BMY
$124B
$111M 0.88%
1,784,876
+90,350
+5% +$5.56M
TSLA icon
17
Tesla
TSLA
$1.4T
$111M 0.88%
464,913
+3,084
+0.7% +$526K
QCOM icon
18
Qualcomm
QCOM
$185B
$110M 0.87%
724,578
+64,171
+10% +$8.94M
BABA icon
19
Alibaba
BABA
$279B
$100M 0.79%
429,666
-20,045
-4% -$5.57M
DIS icon
20
Walt Disney
DIS
$166B
$99.9M 0.79%
551,499
-13,333
-2% -$1.91M
BIIB icon
21
Biogen
BIIB
$29.2B
$95.7M 0.76%
390,870
+23,281
+6% +$6.01M
ALXN
22
DELISTED
Alexion Pharmaceuticals
ALXN
$95.4M 0.75%
610,282
+47,210
+8% +$6.07M
JNJ icon
23
Johnson & Johnson
JNJ
$615B
$95M 0.75%
603,952
+187,791
+45% +$27.7M
SGEN
24
DELISTED
Seagen Inc. Common Stock
SGEN
$89.8M 0.71%
512,643
-4,456
-0.9% -$831K
C icon
25
Citigroup
C
$222B
$89.2M 0.71%
1,446,111
+915,721
+173% +$46.5M

Similar funds

Candriam SCA's Q4 2020 Portfolio in Review

As of Q4 2020, Candriam SCA held 876 positions worth $12.6B, up 19% from $10.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q4 2020 filing shows 80 new, 408 increased, 263 reduced and 68 closed positions. Its largest new stake was Salesforce: 269,070 shares worth $59.9M. The largest sale was Amazon, an estimated $76.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q4 2020 buy was Salesforce: 269,070 shares worth $59.9M.
  • Candriam SCA added most to Apple in Q4 2020, an estimated $146M increase.
  • Candriam SCA's biggest Q4 2020 reduction was Amazon, cutting an estimated $76.3M.
  • Candriam SCA fully exited VIVINT SOLAR, INC. in Q4 2020, selling an estimated $35.6M.
  • Candriam SCA's ten largest holdings make up 21% of its $12.6B portfolio in Q4 2020.
  • Candriam SCA opened 80 new positions and closed 68 in Q4 2020.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $12.6B.

Based on Candriam SCA's 13F filing for Q4 2020, filed 22 Jan 2021.